On the occurrence of the EU presidency, we place the spotlight on suggested EU-legislations affecting IP-rights in the life science industry. With examples from the Swedish life science arena, we show the importance of IP-protection in the journey from academic research to products and therapies for patients.
Publicerat: 02 maj 2023Senast uppdaterat: 08 maj 2023